CAMP
CAMP4 THERAPEUTICS CORPORATIONNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$208.22M
P/E Ratio
—
EPS
$-2.65
Beta
—
52W High
$7.75
52W Low
$1.30
50-Day MA
$4.66
200-Day MA
$3.79
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About CAMP4 THERAPEUTICS CORPORATION
CalAmp Corp. The company is headquartered in Irvine, California.
Fundamentals
| Revenue (TTM) | $3.50M |
| Gross Profit (TTM) | $-34.70M |
| EBITDA | $-50.42M |
| Operating Margin | -3671.00% |
| Return on Equity | -145.10% |
| Return on Assets | -33.20% |
| Revenue/Share (TTM) | $0.12 |
| Book Value | $0.92 |
| Price-to-Book | 4.34 |
| Price-to-Sales (TTM) | 59.53 |
| EV/Revenue | 28.49 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -46.60% |
| Shares Outstanding | $51.93M |
| Float | $29.21M |
| % Insiders | 13.65% |
| % Institutions | 81.98% |
Analyst Ratings
Consensus ($8.20 target)
1
Strong Buy4
Buy1
HoldData last updated: 4/30/2026